Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jul 8:18:3409-3414.
doi: 10.2147/IDR.S530544. eCollection 2025.

A Rare Case Report of Tropheryma Whipplei-Induced Acute Respiratory Distress Syndrome in an Immunocompetent Patient

Affiliations
Case Reports

A Rare Case Report of Tropheryma Whipplei-Induced Acute Respiratory Distress Syndrome in an Immunocompetent Patient

Yidan Fu et al. Infect Drug Resist. .

Abstract

Tropheryma whipplei is a rare gram-positive bacterium traditionally associated with Whipple's disease, primarily presenting with gastrointestinal symptoms. Pulmonary involvement, particularly acute respiratory distress syndrome (ARDS), is extremely rare and poses diagnostic challenges, especially in immunocompetent individuals. We report a rare case of ARDS caused by Tropheryma whipplei in a 28-year-old immunocompetent male with no significant medical history. Traditional diagnostic methods failed to identify the causative pathogen. However, metagenomic next-generation sequencing (mNGS) of bronchoalveolar lavage fluid enabled rapid and accurate detection of T. whipplei, allowing timely initiation of targeted antimicrobial therapy with ceftriaxone and trimethoprim-sulfamethoxazole. The patient demonstrated marked clinical improvement and was discharged with no relapse at follow-up. This case highlights the critical diagnostic value of mNGS in atypical ARDS cases and emphasizes the importance of considering T. whipplei in the differential diagnosis, even among immunocompetent individuals.

Keywords: Tropheryma whipplei; acute respiratory distress syndrome; next-generation sequencing; rare infection; whipple’s disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests in this work.

Figures

Figure 1
Figure 1
Chest CT scans. (AC) Images on hospital day 1 showing bilateral patchy opacities. (DF) Images after 3 weeks of treatment showing resolution of pulmonary exudates.

Similar articles

References

    1. Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the whipple’s-disease-associated bacterium. Lancet. 1991;338(8765):474–475. doi: 10.1016/0140-6736(91)90545-z - DOI - PubMed
    1. Patil S, Fantry GT. Connecting the dots: the many systemic manifestations of whipple disease. Gastroenterol Hepatol (N Y). 2012;8(1):63–66. - PMC - PubMed
    1. Lagier JC, Fenollar F, Raoult D. Acute infections caused by tropheryma whipplei. Future Microbiol. 2017;12(3):247–254. doi: 10.2217/fmb-2017-0178 - DOI - PubMed
    1. Dolmans RA, Boel CH, Lacle MM, Kusters JG. Clinical manifestations, treatment, and diagnosis of tropheryma whipplei infections. Clin Microbiol Rev. 2017;30(2):529–555. doi: 10.1128/CMR.00033-16 - DOI - PMC - PubMed
    1. Deng Y, Zhang H, Lu J, Zhou Z, Zhang T, Cui X. Whipple’s disease of the respiratory system: a case report. Exp Ther Med. 2024;27(4):133. doi: 10.3892/etm.2024.12421 - DOI - PMC - PubMed

Publication types

LinkOut - more resources